Boai NKY Medical Holdings Ltd. (SHE:300109)

China · Delayed Price · Currency is CNY

13.77

+0.19 (1.40%)

Aug 14, 2026, 3:04 PM CST

-4.16% (1Y)

Market Cap	7.99B -4.7%
Revenue (ttm)	1.20B -22.2%
Net Income	174.42M -43.5%
EPS	0.29 -44.8%
Shares Out	580.06M
PE Ratio	46.77
Forward PE	n/a
Dividend	0.17 (1.21%)
Ex-Dividend Date	Jun 23, 2026

Volume	7,237,680
Open	13.63
Previous Close	13.58
Day's Range	13.39 - 13.84
52-Week Range	12.02 - 17.59
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and precision medicine businesses in China and internationally. The company produces and sells polyvinyl pyrrolidone (PVP) series products, vinyl methyl ether/maleic anhydride copolymer (PVM/MA, Euroster) copolymer, and oral care products; and medical technology services, such as early tumor screening, molecular diagnostics, and precision medicine. It also offers pharmaceutical; hazardous chemical; food additive; medical protective equipment; medical device; manufacturing of basic chem... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1987

Employees 1,186

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300109

Full Company Profile

Financial Performance

In 2025, Boai NKY Medical Holdings's revenue was 1.18 billion, a decrease of -26.66% compared to the previous year's 1.61 billion. Earnings were 190.09 million, a decrease of -45.64%.

Financial Statements